
Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing.
Publication
, Other
Levy, JH; Szlam, F; Wolberg, AS; Winkler, A
Published in: Clin Lab Med
September 2014
Although the activated partial thromboplastin time, prothrombin time, and international normalized ratio are widely used in routine preoperative testing, these hemostatic tests are not reliable predictors of perioperative bleeding in patients without known bleeding risk factors. In contrast, a preoperative bleeding history and physical examination are usually obtained in an attempt to identify important bleeding risk factors. However, these coagulation tests are used extensively for monitoring anticoagulation with different pharmacologic agents.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Lab Med
DOI
EISSN
1557-9832
Publication Date
September 2014
Volume
34
Issue
3
Start / End Page
453 / 477
Location
United States
Related Subject Headings
- Prothrombin Time
- Practice Guidelines as Topic
- Postoperative Hemorrhage
- Perioperative Care
- Pathology
- Partial Thromboplastin Time
- Humans
- Evidence-Based Medicine
- Drug Monitoring
- Blood Loss, Surgical
Citation
APA
Chicago
ICMJE
MLA
NLM
Levy, J. H., Szlam, F., Wolberg, A. S., & Winkler, A. (2014). Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing. Clin Lab Med. United States. https://doi.org/10.1016/j.cll.2014.06.005
Levy, Jerrold H., Fania Szlam, Alisa S. Wolberg, and Anne Winkler. “Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing.” Clin Lab Med, September 2014. https://doi.org/10.1016/j.cll.2014.06.005.
Levy JH, Szlam F, Wolberg AS, Winkler A. Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing. Vol. 34, Clin Lab Med. 2014. p. 453–77.
Levy, Jerrold H., et al. “Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing.” Clin Lab Med, vol. 34, no. 3, Sept. 2014, pp. 453–77. Pubmed, doi:10.1016/j.cll.2014.06.005.
Levy JH, Szlam F, Wolberg AS, Winkler A. Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing. Clin Lab Med. 2014. p. 453–477.

Published In
Clin Lab Med
DOI
EISSN
1557-9832
Publication Date
September 2014
Volume
34
Issue
3
Start / End Page
453 / 477
Location
United States
Related Subject Headings
- Prothrombin Time
- Practice Guidelines as Topic
- Postoperative Hemorrhage
- Perioperative Care
- Pathology
- Partial Thromboplastin Time
- Humans
- Evidence-Based Medicine
- Drug Monitoring
- Blood Loss, Surgical